Your browser doesn't support javascript.
loading
Borrelia burgdorferi Is a Poor Inducer of Gamma Interferon: Amplification Induced by Interleukin-12.
van de Schoor, Frederik R; Vrijmoeth, Hedwig D; Brouwer, Michelle A E; Ter Hofstede, Hadewych J M; Lemmers, Heidi L M; Dijkstra, Helga; Boahen, Collins K; Oosting, Marije; Kullberg, Bart-Jan; Hovius, Joppe W; van den Wijngaard, Cees C; van de Veerdonk, Frank L; Netea, Mihai G; Joosten, Leo A B.
Afiliación
  • van de Schoor FR; Radboudumc, Department of Internal Medicine, Radboud Center for Infectious Diseases (RCI) and Radboud Institute of Health Sciences (RIHS), Nijmegen, The Netherlands.
  • Vrijmoeth HD; Radboudumc, Department of Internal Medicine, Radboud Center for Infectious Diseases (RCI) and Radboud Institute of Health Sciences (RIHS), Nijmegen, The Netherlands.
  • Brouwer MAE; Radboudumc, Department of Internal Medicine, Radboud Center for Infectious Diseases (RCI) and Radboud Institute of Health Sciences (RIHS), Nijmegen, The Netherlands.
  • Ter Hofstede HJM; Radboudumc, Department of Internal Medicine, Radboud Center for Infectious Diseases (RCI) and Radboud Institute of Health Sciences (RIHS), Nijmegen, The Netherlands.
  • Lemmers HLM; Radboudumc, Department of Internal Medicine, Radboud Center for Infectious Diseases (RCI) and Radboud Institute of Health Sciences (RIHS), Nijmegen, The Netherlands.
  • Dijkstra H; Radboudumc, Department of Internal Medicine, Radboud Center for Infectious Diseases (RCI) and Radboud Institute of Health Sciences (RIHS), Nijmegen, The Netherlands.
  • Boahen CK; Radboudumc, Department of Internal Medicine, Radboud Center for Infectious Diseases (RCI) and Radboud Institute of Health Sciences (RIHS), Nijmegen, The Netherlands.
  • Oosting M; Radboudumc, Department of Internal Medicine, Radboud Center for Infectious Diseases (RCI) and Radboud Institute of Health Sciences (RIHS), Nijmegen, The Netherlands.
  • Kullberg BJ; Radboudumc, Department of Internal Medicine, Radboud Center for Infectious Diseases (RCI) and Radboud Institute of Health Sciences (RIHS), Nijmegen, The Netherlands.
  • Hovius JW; Amsterdam UMC, University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam Institute of Infection and Immunology, Amsterdam, The Netherlands.
  • van den Wijngaard CC; National Institute for Public Health and the Environment (RIVM), Center of Infectious Disease Control, Bilthoven, The Netherlands.
  • van de Veerdonk FL; Radboudumc, Department of Internal Medicine, Radboud Center for Infectious Diseases (RCI) and Radboud Institute of Health Sciences (RIHS), Nijmegen, The Netherlands.
  • Netea MG; Radboudumc, Department of Internal Medicine, Radboud Center for Infectious Diseases (RCI) and Radboud Institute of Health Sciences (RIHS), Nijmegen, The Netherlands.
  • Joosten LAB; Department of Immunology and Metabolism, Life and Medical Sciences Institute, University of Bonn, Germany.
Infect Immun ; 90(3): e0055821, 2022 03 17.
Article en En | MEDLINE | ID: mdl-35130450
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Lyme / Borrelia burgdorferi Límite: Humans Idioma: En Revista: Infect Immun Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Lyme / Borrelia burgdorferi Límite: Humans Idioma: En Revista: Infect Immun Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos